Dr. Hahn Brings Unparalleled Clinical and Regulatory Expertise to Support Advancement of GX-03 for Moderate-to-Severe Atopic Dermatitis and Pipeline Indications Turn Therapeutics Inc. (Nasdaq: TTRX), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results